Пиперацилин Тазобактам

Основна информация

  • Търговско наименование:
  • Пиперацилин/Тазобактам Каби 2g/0,25g прах за инфузионен разтвор
  • Използвай за:
  • Хората
  • Вид на лекарството:
  • алопатични наркотици

Документи

Локализация

  • Предлага се в:
  • Пиперацилин/Тазобактам Каби 2g/0,25g прах за инфузионен разтвор
    България
  • Език:
  • български

Терапевтична информация

  • Каталог на резюме:
  • Piperacillin/Tazobactam Kabi, 2g/0,25g powder for solution for infusion - 15ml x 1; 15ml x 5; 15ml x 10; 50ml x 1; 50ml x 5; 50ml x 10

Друга информация

Състояние

  • Източник:
  • Изпълнителна агенция по лекарствата - Bulgarian Drug Agency - Bulgaria
  • Номер на разрешението:
  • 20090267
  • Дата Оторизация:
  • 21-10-2015
  • Последна актуализация:
  • 01-06-2018

кратка характеристика на продукта: дозировка, взаимодействия, странични ефекти.

31-7-2018

AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam for Injection 3.375 grams per vial, Due to Presence of Particulates Identified as Glass and Silicone Material

AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam for Injection 3.375 grams per vial, Due to Presence of Particulates Identified as Glass and Silicone Material

East Windsor, New Jersey, AuroMedics Pharma LLC is voluntarily recalling two lots of Piperacillin and Tazobactam for injection, USP 3.375 g (Piperacillin Sodium equivalent to 3 g of Piperacillin USP and Tazobactam Sodium equivalent to 0.375 g of Tazobactam USP. Each vial contains 7.05 mEq (162 mg) of Sodium) in a Single-Dose vial, to the hospital level. One vial from lot# PP0317012-A was found to contain particulate matter, identified as glass within the vial and another vial from lot# PP0317059-A was fo...

FDA - U.S. Food and Drug Administration

8-5-2018

Piperacillin and Tazobactam for Injection, USP 3.375 g Vials by AuroMedics Pharma: Recall - Vials Contain Particulate Matter

Piperacillin and Tazobactam for Injection, USP 3.375 g Vials by AuroMedics Pharma: Recall - Vials Contain Particulate Matter

Piperacillin and Tazobactam for Injection, USP 3.375 g by AuroMedics Pharma: Recall: Exposure to particulate matter may result in local irritation/swelling or more serious outcomes.

FDA - U.S. Food and Drug Administration

Няма новини за този продукт.